Targeting the Microenvironment in MDS: The Final Frontier

Myelodysplastic syndromes (MDS) are a heterogeneous group of malignant disorders of hematopoietic stem and progenitor cells (HSPC), mainly characterized by ineffective hematopoiesis leading to peripheral cytopenias and progressive bone marrow failure. While clonal dominance is nearly universal at di...

Descripción completa

Detalles Bibliográficos
Autores principales: Teodorescu, Patric, Pasca, Sergiu, Dima, Delia, Tomuleasa, Ciprian, Ghiaur, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364152/
https://www.ncbi.nlm.nih.gov/pubmed/32742264
http://dx.doi.org/10.3389/fphar.2020.01044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364152/
https://www.ncbi.nlm.nih.gov/pubmed/32742264
http://dx.doi.org/10.3389/fphar.2020.01044

Ejemplares similares